Trials of psychedelics for mental health may be invalid, because it's fairly obvious to patients whether they've been given a psychedelic or a placebo. Blinding failed more than 90% of the time in the studies of psilocybin, LSD and DMT, and 85% of the time in studies of MDMA.

Trials of psychedelics for mental health may be invalid, because it's fairly obvious to patients whether they've been given a psychedelic or a placebo. Blinding failed more than 90% of the time in the studies of psilocybin, LSD and DMT, and 85% of the time in studies of MDMA.